Latest filingSep 08, 2026Most recent Form 4
PYXS
Pyxis Oncology, Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/08 to 09/08. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$00 sells
Net open-market+$02 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period2transactions
- A · Grants / awards · dominant2 · 100%
Activity by reported role
A joint filing can contribute to multiple roles3transactions
- Chief executive officer · dominant1 · 33%
- CHAIR1 · 33%
- Director1 · 33%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (1)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeDupont JakobStock Option (Right to Buy) · Direct
46,000Aug 20, 2026
Civik ThomasStock Option (Right to Buy) · Direct
2,503,050Sep 04, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 08 → Sep 08
LessMore
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
PYXS transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
No transactions match your filtersOnce the backend ingests and parses SEC filings, they will appear here. Try removing a filter or picking a wider date range. | ||||||||||
Pyxis Oncology, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Pyxis Oncology, Inc.?
Civik Thomas, Dupont Jakob.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.